Literature DB >> 18687414

The microRNA pathway and fragile X mental retardation protein.

Yujing Li1, Li Lin, Peng Jin.   

Abstract

Fragile X syndrome, one of the most common forms of inherited mental retardation, is caused by the functional loss of fragile X mental retardation protein (FMRP). MicroRNAs (miRNAs), a newly discovered class of small noncoding RNAs, have been implicated in multiple biological processes through posttranscriptional gene regulation. Recent evidence supports this view in terms of the biochemical and genetic interaction found between FMRP and the miRNA pathway, providing deeper insight into the molecular pathogenesis of mental retardation. This review briefly summarizes the progress towards an understanding of the role miRNAs play in neurological disorders, with a focus on the mechanism of interaction between FMRP and the miRNA pathway in the context of fragile X syndrome. In addition, we go on to discuss how the miRNA pathway may be involved in mental retardation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687414      PMCID: PMC2607293          DOI: 10.1016/j.bbagrm.2008.07.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  54 in total

1.  Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.

Authors:  T A Comery; J B Harris; P J Willems; B A Oostra; S A Irwin; I J Weiler; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

2.  The fragile X mental retardation protein inhibits translation via interacting with mRNA.

Authors:  Z Li; Y Zhang; L Ku; K D Wilkinson; S T Warren; Y Feng
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

3.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

Review 4.  Advances in molecular analysis of fragile X syndrome.

Authors:  S T Warren; D L Nelson
Journal:  JAMA       Date:  1994-02-16       Impact factor: 56.272

5.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

Review 6.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

7.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

Review 8.  Non coding RNA and brain.

Authors:  Carlo Presutti; Jessica Rosati; Sara Vincenti; Sergio Nasi
Journal:  BMC Neurosci       Date:  2006-10-30       Impact factor: 3.288

9.  Hypothesis: a role for fragile X mental retardation protein in mediating and relieving microRNA-guided translational repression?

Authors:  Isabelle Plante; Patrick Provost
Journal:  J Biomed Biotechnol       Date:  2006

10.  Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation.

Authors:  Lorenzo F Sempere; Sarah Freemantle; Ian Pitha-Rowe; Eric Moss; Ethan Dmitrovsky; Victor Ambros
Journal:  Genome Biol       Date:  2004-02-16       Impact factor: 13.583

View more
  20 in total

1.  Argonaute protein as a linker to command center of physiological processes.

Authors:  Kaifa Wei; Lingjuan Wu; Yanhui Chen; Yina Lin; Yanmei Wang; Xiaoyao Liu; Daoxin Xie
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

Review 2.  MicroRNA in Ovarian Biology and Disease.

Authors:  Lynda K McGinnis; Lacey J Luense; Lane K Christenson
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-18       Impact factor: 6.915

3.  Detecting miRNAs in deep-sequencing data: a software performance comparison and evaluation.

Authors:  Vernell Williamson; Albert Kim; Bin Xie; G Omari McMichael; Yuan Gao; Vladimir Vladimirov
Journal:  Brief Bioinform       Date:  2012-03-24       Impact factor: 11.622

Review 4.  Development and plasticity of the Drosophila larval neuromuscular junction.

Authors:  Kaushiki P Menon; Robert A Carrillo; Kai Zinn
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2013-02-05       Impact factor: 5.814

Review 5.  MicroRNAs: history, biogenesis, and their evolving role in animal development and disease.

Authors:  M Bhaskaran; M Mohan
Journal:  Vet Pathol       Date:  2013-09-17       Impact factor: 2.221

Review 6.  Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics.

Authors:  Marc S Weinberg; Matthew J A Wood
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

Review 7.  MicroRNA implications across neurodevelopment and neuropathology.

Authors:  Sabata Martino; Ilaria di Girolamo; Antonio Orlacchio; Alessandro Datti; Aldo Orlacchio
Journal:  J Biomed Biotechnol       Date:  2009-10-13

8.  The Drosophila gene RanBPM functions in the mushroom body to regulate larval behavior.

Authors:  Nadia Scantlebury; Xiao Li Zhao; Verónica G Rodriguez Moncalvo; Alison Camiletti; Stacy Zahanova; Aidan Dineen; Ji-Hou Xin; Ana Regina Campos
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

9.  Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines.

Authors:  Tewarit Sarachana; Rulun Zhou; Guang Chen; Husseini K Manji; Valerie W Hu
Journal:  Genome Med       Date:  2010-04-07       Impact factor: 11.117

10.  microRNAs and genetic diseases.

Authors:  Nicola Meola; Vincenzo Alessandro Gennarino; Sandro Banfi
Journal:  Pathogenetics       Date:  2009-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.